ERC Not Giving Up On Glioma Immunotherapy In EU

EMA Concerned Over Biosimilar Eptacog Alfa Manufacturing

 
• By Neena Brizmohun

ERC Belgium has pledged to collect more data to convince the European Medicines Agency that Sitoiganap merits approval. Meanwhile, UGA Biopharma said it would address the agency’s objections over its biosimilar version of eptacog alfa.

Close up shot of team of professionals meeting with digital tablet and charts. Business people discussing financial plan. Human hands pointing at grap
More data will be collected for the glioma drug Sitoiganap • Source: Alamy

More from Product Reviews

More from Pink Sheet